News tagged ‘BasicResearch’ clear
- Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.
Tags: BasicResearch, StemCellTransplant, Leukemia
- Dana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.
Tags: BasicResearch, MultipleMyeloma
- Dana-Farber researchers have found a genetic signature in tumors to help them determine if diffuse large B cell lymphoma patients will benefit more from traditional therapies or targeted therapies.
Tags: BasicResearch, Lymphoma
- The SU2C program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.
Tags: BasicResearch, Grants
- A new study by researchers at Dana-Farber shows a small molecule compound called JQ1 can generate reversible birth control in male mice.
- In a study published in the journal Nature, researchers at Dana-Farber Cancer Institute and an international team of associates used a technique involving viral proteins to prioritize which of the many mutated genes in tumor cells are likely involved in cancer and which are mere bystanders.
Tags: BasicResearch, Genomics
- Dana-Farber/Children's Hospital Cancer Center researchers have linked genetic mutations to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children.
Tags: BasicResearch, ChildhoodCancer, Genomics, BrainTumors
- Dana-Farber Cancer Institute researchers have isolated a new type of energy-burning fat cell called "beige fat" in adult humans which they say may have therapeutic potential for treating obesity.
- David Steensma, MD, leads Dana-Farber's efforts as part of a six-institution, $16 million research consortium advancing the treatments and outcomes for patients suffering from Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood.
- Dana-Farber researchers are studying melanoma tumors' microenvironments to better understand how some melanoma continue to grow and survive despite the presence of anti-cancer drugs.
Tags: BasicResearch, Genomics, Melanoma
Showing 31-40 of 122 items